177 related articles for article (PubMed ID: 26505680)
1. Urinary N1, N12-diacetylspermine is a non-invasive marker for the diagnosis and prognosis of non-small-cell lung cancer.
Takahashi Y; Sakaguchi K; Horio H; Hiramatsu K; Moriya S; Takahashi K; Kawakita M
Br J Cancer; 2015 Nov; 113(10):1493-501. PubMed ID: 26505680
[TBL] [Abstract][Full Text] [Related]
2. Significant correlation between urinary N(1), N(12)-diacetylspermine and tumor invasiveness in patients with clinical stage IA non-small cell lung cancer.
Takahashi Y; Horio H; Sakaguchi K; Hiramatsu K; Kawakita M
BMC Cancer; 2015 Feb; 15():65. PubMed ID: 25884987
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of urine N1, N12-diacetylspermine in patients with non-small cell lung cancer.
Kato M; Onishi H; Matsumoto K; Motoshita J; Tsuruta N; Higuchi K; Katano M
Anticancer Res; 2014 Jun; 34(6):3053-9. PubMed ID: 24922672
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of urine N1,N12-Diacetylspermine as potential tumor marker for urinary bladder cancer.
Stejskal D; Humenanska V; Hanulova Z; Fiala R; Vrtal R; Solichova P; Karpisek M
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2006 Nov; 150(2):235-7. PubMed ID: 17426784
[TBL] [Abstract][Full Text] [Related]
5. Gene polymorphisms of SFTPB rs7316, rs9752 and PAOX rs1046175 affect the diagnostic value of plasma Pro-SFTPB and DAS in Chinese Han non-small-cell lung cancer patients.
Wang K; Huang Q; Zhao G; Yang J; Yang K; Huang Y
J Cell Biochem; 2019 Sep; 120(9):14804-14812. PubMed ID: 31016788
[TBL] [Abstract][Full Text] [Related]
6. [Urinary diacetylspermine: its analysis and performance as a novel tumor marker].
Kawakita M; Hiramatsu K; Takahashi K; Yamada R; Kawaguchi M; Shinoura N; Tanaka T; Kariyone K; Tamamori Y; Sasaki Y; Mori T
Rinsho Byori; 2005 Feb; 53(2):123-9. PubMed ID: 15796045
[TBL] [Abstract][Full Text] [Related]
7. Urinary malate dehydrogenase 2 is a new biomarker for early detection of non-small-cell lung cancer.
Ma YC; Tian PF; Chen ZP; Yue DS; Liu CC; Li CG; Chen C; Zhang H; Liu HL; Zhang ZF; Chen L; Zhang B; Wang CL
Cancer Sci; 2021 Jun; 112(6):2349-2360. PubMed ID: 33565687
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of urinary N1,N12-diacetylspermine levels in patients with hepatocellular carcinoma.
Enjoji M; Nakamuta M; Arimura E; Morizono S; Kuniyoshi M; Fukushima M; Kotoh K; Nawata H
Int J Biol Markers; 2004; 19(4):322-7. PubMed ID: 15646840
[TBL] [Abstract][Full Text] [Related]
9. Urinary N
Yokota K; Hinoki A; Hiramatsu K; Amano H; Kawamura M; Kuwatsuka Y; Tainaka T; Shirota C; Sumida W; Makita S; Okamoto M; Takimoto A; Yasui A; Nakagawa Y; Uchida H; Kawakita M
Pediatr Surg Int; 2021 Dec; 37(12):1659-1665. PubMed ID: 34453590
[TBL] [Abstract][Full Text] [Related]
10. Midkine is a serum and urinary biomarker for the detection and prognosis of non-small cell lung cancer.
Xia X; Lu JJ; Zhang SS; Su CH; Luo HH
Oncotarget; 2016 Dec; 7(52):87462-87472. PubMed ID: 27974680
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic and prognostic value of plasma microRNA-195 in patients with non-small cell lung cancer.
Su K; Zhang T; Wang Y; Hao G
World J Surg Oncol; 2016 Aug; 14(1):224. PubMed ID: 27733164
[TBL] [Abstract][Full Text] [Related]
12. Investigation of serum miR-411 as a diagnosis and prognosis biomarker for non-small cell lung cancer.
Wang SY; Li Y; Jiang YS; Li RZ
Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4092-4097. PubMed ID: 29028091
[TBL] [Abstract][Full Text] [Related]
13. Urinary cell-free DNA as a prognostic marker for KRAS-positive advanced-stage NSCLC.
Xie F; Li P; Gong J; Tan H; Ma J
Clin Transl Oncol; 2018 May; 20(5):591-598. PubMed ID: 28956302
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic and prognostic value of serum thioredoxin and DJ-1 in non-small cell lung carcinoma patients.
Fan J; Yu H; Lv Y; Yin L
Tumour Biol; 2016 Feb; 37(2):1949-58. PubMed ID: 26334622
[TBL] [Abstract][Full Text] [Related]
15. [Clinical usefulness of urinary diacetylpolyamines as novel tumor markers].
Kawakita M; Hiramatsu K; Sugimoto M; Takahashi K; Toi M
Rinsho Byori; 2004 Apr; 52(4):321-7. PubMed ID: 15164599
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-486 as a Biomarker for Early Diagnosis and Recurrence of Non-Small Cell Lung Cancer.
Li W; Wang Y; Zhang Q; Tang L; Liu X; Dai Y; Xiao L; Huang S; Chen L; Guo Z; Lu J; Yuan K
PLoS One; 2015; 10(8):e0134220. PubMed ID: 26237047
[TBL] [Abstract][Full Text] [Related]
17. The variation of prognostic significance of Maximum Standardized Uptake Value of [18F]-fluoro-2-deoxy-glucose positron emission tomography in different histological subtypes and pathological stages of surgically resected Non-Small Cell Lung Carcinoma.
Casali C; Cucca M; Rossi G; Barbieri F; Iacuzio L; Bagni B; Uliano M
Lung Cancer; 2010 Aug; 69(2):187-93. PubMed ID: 19942313
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of urinary plasminogen and fibrinogen gamma chain as novel potential diagnostic markers for non-small-cell lung cancer.
Zhang W; Gao Z; Zeng G; Xie H; Liu J; Liu N; Wang G
Clin Chim Acta; 2020 Mar; 502():55-65. PubMed ID: 31821791
[TBL] [Abstract][Full Text] [Related]
19. Prognostic effect of matrix metalloproteinase-9 in patients with resected Non small cell lung cancer.
Lee CY; Shim HS; Lee S; Lee JG; Kim DJ; Chung KY
J Cardiothorac Surg; 2015 Mar; 10():44. PubMed ID: 25888323
[TBL] [Abstract][Full Text] [Related]
20. [Value of metastatic lymph node ratio in predicting the prognosis of non-small cell lung cancer patients].
Li Y; Sun BS; Zhang ZF; Zhang LM; Wang CL
Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(24):1682-6. PubMed ID: 21914316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
